INTRA ABDOMINAL PRESSURE MEASUREMENT DEVICES MARKET ANALYSIS

Market Challenges And Opportunities

Global Intra Abdominal Pressure Measurement Devices Market – Driver

Development of di-(2-ethylhexyl) phthalate (DEHP) free products is expected to drive the market

The development of di-(2-ethylhexyl) phthalate (DEHP)-free products is expected to boost the growth of the global intra abdominal pressure monitoring devices market during the forecast period. DEHP is often used in the medical device industry as a plasticizer for various plastic materials to make them plastic flexible. The use of these phthalates in the device or disposable manufacturing process can suppress testosterone production in the adult testicles and affect reproductive health. Therefore, market players are focusing on providing alternatives to DHEP, such as DEHT (di-(2-ethylhexyl) terephthalate), which is not genotoxic and does not cause reproductive toxicity. For instance, On Febuary 26, 020, Sun Pharmaceutical Industries Ltd., a Pharmaceutical company has  launched Riomet ER in the U.S. as a dietary supplement and exercise supplement to improve glucose control in patients 10 years of age and older with type 2 diabetes.

Global Intra Abdominal Pressure Measurement Devices Market: Restraint

Complications associated with pressure measurement devices  

Procedural complications are expected to hinder the growth of the global intra-abdominal pressure monitoring devices market. Endodominal pressure is usually measured through the patient's bladder. Some of the most serious problems associated with pressure control devices include bladder infections and needlestick injuries, which can cause patient discomfort and increase the risk of compliance. Although several publications have been published in the recent past, for instance, the data published in the Journal of Wound, Ostomy and Continence Nursing in June 2022, IAP measurement techniques and clinical applicability are not yet fully established. Intravesical IAP measurement is consensual. However, there are issues related to the zero point, infusion volume, measurement frequency, and indications. Such a scenario is also expected to hinder the growth of the market.